Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Maria I. Chianese"'
Autor:
Maria Rita Milone, Biagio Pucci, Alessandra Leone, Michele Caraglia, Maria I. Chianese, Renato Franco, Alfredo Budillon, Francesca Bruzzese, E. Di Gennaro, Monia Rocco, Daniele Santini, Claudio Arra, Chiara Ciardiello, Antonio Luciano
Publikováno v:
Cell Death & Disease
Patients with advanced prostate cancer (PCa) and multiple myeloma (MM) have limited long-term responses to available therapies. The histone deacetylase inhibitor panobinostat has shown significant preclinical and clinical anticancer activity in both
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7c08f278ee82ab44b79d74dbe727b4d
http://hdl.handle.net/11591/184192
http://hdl.handle.net/11591/184192
Autor:
Antonio Luciano, Renato Franco, A Di Cintio, Maria I. Chianese, I de Ruggiero, Francesca Bruzzese, E. Di Gennaro, Geny Piro, Alfredo Budillon, A. Avallone, Claudio Arra, Tania Moccia
Publikováno v:
British Journal of Cancer
Background: Potentiation of anticancer activity of capecitabine is required to improve its therapeutic index. In colorectal cancer (CRC) cells, we evaluated whether the histone deacetylase-inhibitor vorinostat may induce synergistic antitumour effect
Autor:
Alessandra Di Cintio, Geny Piro, Alfredo Budillon, Elena Di Gennaro, Francesca Bruzzese, Maria I. Chianese
Publikováno v:
Cancer Research. 71:3519-3519
Capecitabine is a pro-drug which was designed to take advantage of the increased levels of thymidine phosphorylase (TP), a key enzyme for its conversion to 5-florouracil (5-FU), observed in tumours as opposed to normal tissues, potentially allowing f
Autor:
Alessandra Leone, Secondo Lastoria, Alfredo Budillon, Paolo Delrio, Rosario Vincenzo Iaffaioli, Elena Di Gennaro, Luigi Aloi, Antonio Avallone, Maria I. Chianese, Pasquale Comella, Corradina Caracò, Biagio Pecori
Publikováno v:
Cancer Research. 70:3721-3721
Vascular endothelial growth factor (VEGF) has a crucial role in tumor angiogenesis, and its inhibition by bevacizumab (BEV) leads to normalization of tumor vessels increasing tumor oxygenation and drug delivery. However, the clinical benefits of curr
Autor:
Antonio Luciano, Geny Piro, Alfredo Budillon, Francesca Bruzzese, Alessandra Di Cintio, Claudio Arra, Maria I. Chianese, Tania Moccia, Elena Di Gennaro
Publikováno v:
Cancer Research. 70:5442-5442
The oral fluoropyrimidine capecitabine is converted to the active compound 5-florouracil (5-FU) in several steps, the last of which is the conversion of 5′-deoxy-5-fluorouridine (5′DFUR) to 5-FU by thymidine phosphorylase (TP). Capecitabine was d